DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx appoints Omar Duramad, Ph.D. as Chief Scientific Officer to lead preclinical development of bryostatin and analogues…
DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx appoints Omar Duramad, Ph.D. as Chief Scientific Officer to lead preclinical development of bryostatin and analogues…